Physician profile
Vivek Dutt
NPI 1497164354
$2,631.87
in general payments reported to CMS, 2019-2025
8 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.72 · 2022: $40.43 · 2023: $922 · 2024: $1,427 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,729 · Food and Beverage: $672 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,728.50 |
| Food and Beverage | $671.97 |
| Consulting Fee | $150.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $901.45 | 2023 | |
| Conetic Solutions, INC. | $786.36 | 2024 | |
| Arthrex, INC. | $625.30 | 2024 | |
| Stryker Corporation | $182.85 | 2023-2025 | Variax, Fixos, Prostep Mica |
| Orthofix Medical, INC. | $55.92 | 2022-2024 | Fitbone |
| Biomarin Pharmaceutical INC. | $40.72 | 2020 | |
| Depuy Synthes Sales INC. | $21.85 | 2025 | Na |
| Bioventus LLC | $17.42 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Dutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.